Microsatellite instability in prostate cancer and response to immune checkpoint blockade.

被引：8

作者：

Abida, Wassim ^{[1
]}

Cheng, Michael L. ^{[1
]}

Armenia, Joshua ^{[1
]}

Middha, Sumit ^{[1
]}

Autio, Karen A. ^{[1
]}

Rathkopf, Dana E. ^{[1
]}

Morris, Michael J. ^{[1
]}

Danila, Daniel Costin ^{[1
]}

Slovin, Susan F. ^{[1
]}

Carbone, Emily ^{[1
]}

Hullings, Melanie ^{[1
]}

Hechtman, Jaclyn Frances ^{[1
]}

Reuter, Victor E. ^{[1
]}

Berger, Michael F. ^{[1
]}

Kantoff, Philip W. ^{[1
]}

Sawyers, Charles L. ^{[1
]}

Schultz, Nikolaus ^{[1
]}

Solit, David B. ^{[1
]}

Gopalan, Anuradha ^{[1
]}

Scher, Howard I. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.5020

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5020

引用

页数：1

共 50 条

[41] Predicting mechanism of immune response in microsatellite instability colorectal cancer
Sun, Peng
Luan, Yusong
Cai, Xuhao
Liu, Qi
Ren, Peide
Xin, Pengpan
Yu, Yonggang
Song, Bolun
Wang, Yangyang
Chang, Huijing
Ma, Haoyue
Chen, Yinggang
[J]. HELIYON, 2024, 10 (06)
[42] Microsatellite Instability as a Predictor of Outcomes in Colorectal Cancer in the Era of Immune-Checkpoint Inhibitors
Lengyel, Csongor Gyoergy
[J]. CURRENT DRUG TARGETS, 2021, 22 (09) : 968 - 976
[43] Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer
Sui, Qiaoqi
Zhang, Xi
Chen, Chao
Tang, Jinghua
Yu, Jiehai
Li, Weihao
Han, Kai
Jiang, Wu
Liao, Leen
Kong, Lingheng
Li, Yuan
Hou, Zhenlin
Zhou, Chi
Zhang, Chenzhi
Zhang, Linjie
Xiao, Binyi
Mei, Weijian
Xu, Yanbo
Qin, Jiayi
Zheng, Jian
Pan, Zhizhong
Ding, Pei-Rong
[J]. NATURE COMMUNICATIONS, 2022, 13 (01)
[44] Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer
Qiaoqi Sui
Xi Zhang
Chao Chen
Jinghua Tang
Jiehai Yu
Weihao Li
Kai Han
Wu Jiang
Leen Liao
Lingheng Kong
Yuan Li
Zhenlin Hou
Chi Zhou
Chenzhi Zhang
Linjie Zhang
Binyi Xiao
Weijian Mei
Yanbo Xu
Jiayi Qin
Jian Zheng
Zhizhong Pan
Pei-Rong Ding
[J]. Nature Communications, 13
[45] Immune checkpoint blockade in ovarian cancer
Weiss, Lukas
Huemer, Florian
Mlineritsch, Brigitte
Greil, Richard
[J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2016, 9 (02) : 82 - 84
[46] Immune Checkpoint Blockade in Cancer Therapy
Postow, Michael A.
Callahan, Margaret K.
Wolchok, Jedd D.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (17) : 1974 - U161
[47] Immune checkpoint blockade for ovarian cancer
Hamanishi, Junzo
[J]. ANNALS OF ONCOLOGY, 2021, 32 : S259 - S259
[48] Immune toxicity in post autologous transplant patients treated with brentuximab vedotin in combination with immune checkpoint blockade.
Diefenbach, Catherine S. Magid
Hong, Fangxin
Ambinder, Richard F.
Cohen, Jonathon Brett
David, Kevin Andrew
Advani, Ranjana H.
Robertson, Michael J.
Fenske, Timothy S.
Barta, Stefan K.
Palmisano, Neal
Svoboda, Jakub
Morgan, David S.
Karmali, Reem
Kahl, Brad
Ansell, Stephen M.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[49] Immune checkpoint expression, microsatellite instability, and mutational burden: Identifying immune biomarker phenotypes in uterine cancer
Jones, Nathaniel L.
Xiu, Joanne
Rocconi, Rodney P.
Herzog, Thomas J.
Winer, Ira S.
[J]. GYNECOLOGIC ONCOLOGY, 2020, 156 (02) : 393 - 399
[50] Immune checkpoint expression, microsatellite instability, and mutational burden: Identifying immune biomarker phenotypes in uterine cancer
Jones, N. L.
Xiu, J.
Herzog, T.
Winer, I.
[J]. GYNECOLOGIC ONCOLOGY, 2018, 149 : 44 - 44

← 1 2 3 4 5 →